A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica
Clinical trial NCT02477917 · COMPLETED
Trial details
- NCT number
- NCT02477917
- Sponsor
- Roxall Medicina España S.A
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-03-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.